In Brief: FDA restructuring
This article was originally published in The Tan Sheet
Executive Summary
FDA restructuring: Senate Labor & Human Resources Committee hearing on proposals to revise and restructure the operations of FDA has been rescheduled to March 19 from March 18 ("The Tan Sheet" March 3, p. 23). The hearing is expected to address renewal of the Prescription Drug User Fee Act, among other issues. Sen. James Jeffords (R-Vt.) is slated to commence the hearing at 9:30 a.m. in the Dirksen Building, Room SD-430...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning